NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE28797 Query DataSets for GSE28797
Status Public on Jun 08, 2011
Title Smad2/3 binding sites in HaCaT, HepG2, and Hep3B cells determined by an Affymetrix promoter array
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by genome tiling array
Summary Specific regulation of target genes by transforming growth factor-β (TGF-β) in a given cellular context is determined in part by transcription factors and cofactors that interact with the Smad complex. In the present study, we determined Smad2 and Smad3 (Smad2/3) binding regions in the promoters of known genes in HepG2 hepatoblastoma cells, and compared them to those in HaCaT epidermal keratinocytes to elucidate the mechanisms of cell-type- and context-dependent regulation of transcription induced by TGF-β. Our results show that 81% of the Smad2/3 binding regions in HepG2 cells were not shared with those found in HaCaT cells. Hepatocyte nuclear factor 4α (HNF4α) is expressed in HepG2 cells, but not in HaCaT cells, and the HNF4α binding motif was identified as an enriched motif in the HepG2-specific Smad2/3 binding regions. ChIP-sequencing analysis of HNF4α binding regions under TGFα stimulation revealed that 32.5% of the Smad2/3 binding regions overlapped HNF4α bindings. MIXL1 was identified as a new combinatorial target of HNF4α and Smad2/3, and both the HNF4α protein and its binding motif were required for the induction of MIXL1 by TGF-β in HepG2 cells. These findings generalize the importance of binding of HNF4α on Smad2/3 binding genomic regions for HepG2-specific regulation of transcription by TGF-β, and suggest that certain transcription factors expressed in a cell-type-specific manner play important roles in the transcription regulated by the TGF-β-Smad signaling pathway.
 
Overall design We determined and analyzed cell-line-specific Smad2/3 binding sites by ChIP-chip. HaCaT, HepG2, and Hep3B cells were treated with TGF-β for 1.5 h. anti-Smad2/3 ChIP samples and their input DNAs were hybridized to the arrays. Each bed file contains Smad2/3 binding sites determined by two-sample analysis (NCBIv36/hg18, p<10-4).
 
Contributor(s) Mizutani A, Koinuma D, Tsutsumi S, Kamimura N, Morikawa M, Suzuki H, Miyazono K, Aburatani H
Citation(s) 21646355
Submission date Apr 21, 2011
Last update date Jan 21, 2015
Contact name Daizo Koinuma
E-mail(s) d-koinuma@umin.ac.jp
Organization name University of Tokyo
Department Pathology
Street address Hongo 7-3-1, Bunkyo-ku
City Tokyo
ZIP/Postal code 113-0033
Country Japan
 
Platforms (1)
GPL5082 [Hs_PromPR] Affymetrix Human Promoter 1.0R Array
Samples (3)
GSM713225 HepG2_Smad2/3_ChIP-chip
GSM713226 Hep3B_Smad2/3_ChIP-chip
GSM738220 HaCaT_Smad2/3_ChIP-chip
This SubSeries is part of SuperSeries:
GSE28798 Cell-type-specific target selection by combinatorial binding of Smad2/3 and hepatocyte nuclear factor 4-alpha in HepG2 cells
Relations
BioProject PRJNA143093

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE28797_RAW.tar 289.6 Mb (http)(custom) TAR (of BAR, BED, CEL)
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap